Total Payments
$11,209
2024 Payments
$3,724
Companies
29
Transactions
99
Medicare Patients
1,755
Medicare Billing
$285,925
Payment Breakdown by Category
Other$8,130 (72.5%)
Food & Beverage$2,563 (22.9%)
Education$516.10 (4.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,500 | 7 | 40.1% |
| Honoraria | $3,630 | 5 | 32.4% |
| Food and Beverage | $2,563 | 80 | 22.9% |
| Education | $516.10 | 7 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $5,376 | 20 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $3,656 | 8 | $0 (2021) |
| Astellas Pharma US Inc | $418.00 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $342.31 | 7 | $0 (2024) |
| Kite Pharma, Inc. | $271.19 | 8 | $0 (2023) |
| PFIZER INC. | $118.77 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $111.65 | 5 | $0 (2024) |
| Epizyme, Inc., | $103.43 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $89.00 | 1 | $0 (2023) |
| GENZYME CORPORATION | $79.05 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,724 | 42 | AstraZeneca Pharmaceuticals LP ($2,884) |
| 2023 | $3,067 | 20 | AstraZeneca Pharmaceuticals LP ($2,438) |
| 2022 | $467.63 | 17 | Kite Pharma, Inc. ($121.52) |
| 2021 | $3,950 | 20 | Karyopharm Therapeutics Inc. ($3,656) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/19/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: HORMONE THERAPY | ||||||
| 12/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $68.00 | General |
| 12/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/10/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $27.18 | General |
| 12/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Oncology | ||||||
| 12/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $29.74 | General |
| 11/27/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Oncology | ||||||
| 11/06/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/25/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $62.97 | General |
| Category: Oncology | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Education | In-kind items and services | $86.98 | General |
| Category: Oncology | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Oncology | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.50 | General |
| 05/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Rare Disease | ||||||
| 05/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 438 | 867 | $246,929 | $75,852 |
| 2022 | 3 | 465 | 864 | $255,549 | $78,262 |
| 2021 | 3 | 396 | 747 | $226,298 | $76,187 |
| 2020 | 3 | 456 | 797 | $216,576 | $55,623 |
Total Patients
1,755
Total Services
3,275
Medicare Billing
$285,925
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 154 | 394 | $134,748 | $42,807 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 402 | $101,706 | $30,156 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 54 | $9,234 | $2,541 | 27.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 11 | 17 | $1,241 | $348.50 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 203 | 465 | $159,030 | $50,487 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 345 | $87,285 | $25,301 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 54 | $9,234 | $2,473 | 26.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 196 | 433 | $148,086 | $50,798 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 186 | 299 | $75,647 | $24,618 | 32.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $2,565 | $770.38 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 269 | 564 | $142,692 | $36,774 | 25.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 145 | 189 | $64,638 | $16,819 | 26.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 44 | $9,246 | $2,030 | 22.0% |
About Jillian Oakleaf
Jillian Oakleaf is a Family healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2016. The National Provider Identifier (NPI) number assigned to this provider is 1477904050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jillian Oakleaf has received a total of $11,209 in payments from pharmaceutical and medical device companies, with $3,724 received in 2024. These payments were reported across 99 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,500).
As a Medicare-enrolled provider, Oakleaf has provided services to 1,755 Medicare beneficiaries, totaling 3,275 services with total Medicare billing of $285,925. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Tulsa, OK
- Active Since 06/25/2016
- Last Updated 10/10/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1477904050
Products in Payments
- CALQUENCE (Drug) $5,127
- XPOVIO (Drug) $3,656
- TECVAYLI (Biological) $278.77
- LYNPARZA (Drug) $115.89
- TAZVERIK (Drug) $103.43
- XTANDI (Drug) $84.59
- Enhertu (Drug) $72.72
- Xospata (Drug) $63.96
- TAGRISSO (Drug) $62.97
- PROVENGE (Drug) $51.07
- LIBTAYO (Biological) $46.15
- JELMYTO (Drug) $42.84
- SOMATULINE DEPOT (Drug) $41.83
- VENCLEXTA (Drug) $40.00
- PADCEV (Biological) $34.71
- KEYTRUDA (Biological) $31.05
- PROLARIS (Device) $27.83
- KISQALI (Drug) $27.04
- ADCETRIS (Biological) $25.53
- LUMAKRAS (Drug) $24.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tulsa
Mr. Jeremy Morgan, Aprn, APRN
Family — Payments: $33,967
Family $33,967
Candy Williams, Aprn, Cnp, APRN, CNP
Family — Payments: $14,546
Family $14,546
Mrs. Erin Rowan, Aprn, APRN
Family — Payments: $11,107
Family $11,107
Mr. Lee Matlock, Aprn, APRN
Family — Payments: $11,074
Family $11,074
Teresa Donnell, Aprn, APRN
Family — Payments: $9,114
Family $9,114
Cristina Barnes, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $9,107
Family $9,107